2 results  1 of 1 

1 Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
Kyung-Nam Koh, Ho Joon Im, Hyery Kim, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo, Young Tak Lim, Jun Eun Park, Byung-Kiu Park, Hyeon Jin Park, Jong Jin Seo
J Korean Med Sci.2017;32(4):642-649.   Published online 2017 February 13     DOI: http://dx.doi.org/10.3346/jkms.2017.32.4.642
      
2 Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
Jong Hyung Yoon, Jeong Ah Park, Eun Kyung Kim, Hyoung Jin Kang, Hee Young Shin, Hyo Seop Ahn
J Korean Med Sci.2009;24(2):281-288.   Published online 2009 April 20     DOI: http://dx.doi.org/10.3346/jkms.2009.24.2.281
      

 1 of 1